title: Evaluation of in vitro cytotoxicity and paracellular permeability of intact monolayers with mouse embryonic stem cells.
abstract: Mouse embryonic stem (mES) cells were induced to form intact monolayers in cell culture inserts, using combinations of extracellular matrix (ECM) components and growth factors (GFs). Progressive formation of intact monolayers was monitored using transepithelial electrical resistance (TEER) and passage of paracellular permeability (PP) markers. The mES cells were initially inoculated on inactivated mouse embryonic fibroblasts (MEFs) plus leukemia inhibitory factor (LIF). At 75% confluence, cells were passaged in the absence of MEF and LIF to stimulate formation of rounded multicellular aggregates (MA). After 4 days, cultures containing MA were transferred to culture inserts coated with ECM components only, and grown in the presence of selected individual GFs. An additional 10-14 days revealed confluent monolayers with TEER values of 500-700 ohms cm2 (Omega cm2). Monolayers grown on inserts coated with ECM components, such as fibronectin or collagen-IV, in the presence of epidermal growth factor or keratinocyte growth factor in the medium, yielded the highest TEER measurements when compared to cultures grown without GFs or ECM. Acute cytotoxicity (AC) studies with confluent monolayers of mES cells in 96-well plates indicated that there is a high correlation (R2=0.91) between cell viability and TEER for 24-h exposure time. Also, decrease in TEER is inversely proportional with increase in PP of markers. In comparison to standardized Registry of Cytotoxicity (RC) data and TEER measurements, MTT IC50 values for mES cells are lower. Thus, at equivalent concentrations for the same chemicals, cell viability decreases before the integrity of the monolayer is compromised. This system represents a novel approach for the manipulation of mES cells toward specific intact monolayers, as an in vitro model for biological monolayer formation, and most importantly, for applications to cytotoxicity testing.
authors.affiliation: St. John's University College of Pharmacy and Allied Health Professions, Department of Pharmaceutical Sciences, Toxicology Division, 8000 Utopia Parkway, Queens, NY 11439, United States.
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Calabro
authors.forename: Roula
authors.initials: R
authors.lastname: Konsoula
authors.forename: Frank A
authors.initials: FA
authors.lastname: Barile
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques / Q000379:methods; D002460:Cell Line; D002463:Cell Membrane Permeability / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D017097:Electric Impedance; D053595:Embryonic Stem Cells / Q000187:drug effects* / Q000473:pathology; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D005562:Formazans / Q000378:metabolism; D020128:Inhibitory Concentration 50; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D053605:Leukemia Inhibitory Factor / Q000378:metabolism; D051379:Mice; D013778:Tetrazolium Salts / Q000378:metabolism; D015262:Xenobiotics / Q000378:metabolism / Q000633:toxicity*
chemical_list: D016326:Extracellular Matrix Proteins; D005562:Formazans; D036341:Intercellular Signaling Peptides and Proteins; D053605:Leukemia Inhibitory Factor; D013778:Tetrazolium Salts; D015262:Xenobiotics; C079782:MTT formazan